Recurrent Adult Diffuse Small Cleaved Cell Lymphoma: Clinical Trials

2 trials for Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 2

Follow Recurrent Adult Diffuse Small Cleaved Cell Lymphoma: new trials by email Literature Review of Recurrent Adult Diffuse Small Cleaved Cell Lymphoma trials Research Report on Recurrent Adult Diffuse Small Cleaved Cell Lymphoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant
busulfan, etoposide, cyclophosphamide - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma
Early Phase 1CompletedCase Comprehensive Cancer Center332014-03-012015-08-13
Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma
rituximab, cyclophosphamide, filgrastim - Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma
Early Phase 1CompletedNational Cancer Institute (NCI)302001-04-012013-01-09

Narrower conditions

Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Lymphoma, B-Cell, Marginal Zone (2)  ·  Lymphoma, Follicular (2)  ·  Lymphoma, Large B-Cell, Diffuse (2)  ·  Lymphoma, Mantle-Cell (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Waldenstrom Macroglobulinemia (2)  ·  Burkitt Lymphoma (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Hodgkin Disease (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Intraocular Lymphoma (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)

Broader conditions

Blood Protein Disorders (2)  ·  Cardiovascular Diseases (2)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hemorrhagic Disorders (2)  ·  Hemostatic Disorders (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia (2)  ·  Leukemia, B-Cell (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)

Interventions

Cyclophosphamide (2)  ·  Peripheral Blood Stem Cell Transplantation (2)  ·  Busulfan (1)  ·  Etoposide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Rituximab (1)  ·  ibritumomab tiuxetan (1)

Sponsors

Case Comprehensive Cancer Center (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)

Top investigators

Brian Hill, MD (1)  ·  Lode Swinnen (1)

NIH funding

P30CA043703 (1)